We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Key to TGF-Beta Growth Stimulation Found

By Biotechdaily staff writers
Posted on 23 Dec 2003
Researchers have identified a group of proteins that when present inhibit the activity of transforming growth factor-beta (TGF-b) and prevent cell transformation.

TGF-b is known to function as both a growth stimulator and growth suppressor. To explain this apparent paradox, researchers at Vanderbilt University (Nashville, TN, USA; www.vanderbilt.edu) genetically engineered a line of cells lacking the TGF-b signaling proteins Rho-ROCK. They found that these cells, which derived from a line normally not affected by TGF-b, were readily transformed by the growth factor. Addition of extraneous Rho-Rock proteins restored the inhibition to TGF-b growth stimulation. These findings were published in the December 1, 2003, online edition of the Proceedings of the [U.S.] National Academy of Sciences.

"TGF-b usually causes cell growth inhibition; however, many solid tumors overexpress TGF-b and the cells are not inhibited at all--in fact, sometimes they grow faster than normal as a result of TGF-b signaling,” explained first author Dr. Neil A. Bhowmick, assistant professor of urologic surgery at Vanderbilt University. "Perhaps inactivation of this pathway is a way that cancer cells override the normal growth-suppressing activity of TGF-b.”




Related Links:
Vanderbilt University

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Total Laboratory Automation Solution
SATLARS Mini T8
New
HPV Test
Allplex HPV28 Detection

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
23 Dec 2003  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
23 Dec 2003  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
23 Dec 2003  |   BioResearch